Mayne Pharma, which already operates a big production plant in Greenville, is going to add as many as 110 jobs as part of a $65 million expansion plan. Jobs include scientists, manufacturing and other positions.

The company will receive some $2.7 million in tax and other incentives, including a $550,000 One North Carolina Fund grant.

The expansion is the second big life science deal for North Carolina this week. Novo Nordisk plans to add almost 700 jobs in a huge expansion in Clayton.

Mayne announced the expansion Thursday. The company currently has 350 employees in Greenville.

The expansion includes a new 126,000 square foot manufacturing building for oral-dose production as well as “repurposing” of existing space, the company said. The additions will “more than double” its manufacturing capabilities in the U.S.

“Expanding our Greenville operations solidifies Mayne Pharma’s aspirations in the U.S. market, while building our talented workforce,” said Stefan Cross, president of Mayne Pharma USA, in the announcement.

“Once operational, we can take on new and larger products, specifically those that rely upon our company’s drug-delivery and potent handling expertise.”

Mayne, which is based in Australia, offers product manufacturing as well as contract development and manufacturing services.

The Greenville operation is built around Metrics Contract Services, which launched in 1994 and was acquired by Mayne in 2012 for $120 million.

Mayne operations in the U.S. include:

• Metrics Contract Services, which provides contract pharmaceutical development services to third parties globally

• U.S. Generic Products, which develops, manufactures, markets and distributes generic drug products

• U.S. Specialty Brands, which is responsible for the marketing and distribution of branded pharmaceuticals within the United States.

“Mayne Pharma has a 30-year track record of innovation and success in developing pharmaceutical products, and the company’s plans to expand facilities and services in eastern North Carolina are key to its business development efforts worldwide,” said N.C. Governor Pat McCrory. “This important expansion speaks volumes about the appeal our state has for companies at every stage of their growth.”